Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7851
CALL
Laureate Education
LAUR
$5.25B
| $678K | ﹤0.01% |
58,600
+11,600
| +25% | +$137K |
|
7852
PUT
TaskUs
TASK
$663M
| $678K | ﹤0.01% |
40,200
-79,600
| -66% | -$2.03M |
|
7853
PUT
Ziff Davis
ZD
$1.9B
| $678K | ﹤0.01% |
9,100
+1,900
| +26% | +$157K |
|
|
FOCS
7854
PUT
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $678K | ﹤0.01% |
19,900
-15,100
| -43% | -$577K |
|
|
AQUA
7855
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $678K | ﹤0.01% |
20,860
-24,332
| -54% | -$926K |
|
|
API
7856
Agora
API
$373M
| $677K | ﹤0.01% |
103,147
+49,327
| +92% | +$349K |
|
|
AZUL
7857
CALL
DELISTED
Azul
AZUL
| $677K | ﹤0.01% |
95,400
-58,100
| -38% | -$700K |
|
7858
Pediatrix Medical
MD
$2.18B
| $677K | ﹤0.01% |
32,208
-116,851
| -78% | -$2.38M |
|
|
ONTF
7859
CALL
DELISTED
ON24
ONTF
| $677K | ﹤0.01% |
71,300
+6,400
| +10% | +$77.6K |
|
7860
CALL
Rackspace Technology
RXT
$930M
| $677K | ﹤0.01% |
94,400
+28,900
| +44% | +$261K |
|
7861
PUT
Thomson Reuters
TRI
$43.9B
| $677K | ﹤0.01% |
6,169
-854
| -12% | -$90.5K |
|
7862
PUT
CACI
CACI
$14.7B
| $676K | ﹤0.01% |
2,400
-800
| -25% | -$223K |
|
7863
Duluth Holdings
DLTH
$149M
| $676K | ﹤0.01% |
70,793
+7,615
| +12% | +$88.6K |
|
7864
Gerdau
GGB
$9.28B
| $676K | ﹤0.01% |
198,563
-97,349
| -33% | -$433K |
|
7865
VanEck Morningstar International Moat ETF
MOTI
$75.8M
| $676K | ﹤0.01% |
23,409
+2,436
| +12% | +$73.7K |
|
7866
CALL
Planet Labs
PL
$8.41B
| $676K | ﹤0.01% |
156,200
+41,200
| +36% | +$213K |
|
7867
CALL
Superior Group of Companies
SGC
$204M
| $676K | ﹤0.01% |
38,100
-12,100
| -24% | -$208K |
|
7868
Adtran
ADTN
$661M
| $675K | ﹤0.01% |
38,497
+12,503
| +48% | +$226K |
|
7869
CALL
Ichor Holdings
ICHR
$2.48B
| $675K | ﹤0.01% |
26,000
+4,800
| +23% | +$139K |
|
7870
CALL
iShares US Energy ETF
IYE
$1.86B
| $675K | ﹤0.01% |
17,700
+2,400
| +16% | +$102K |
|
7871
Schwab US Large- Cap ETF
SCHX
$74.2B
| $675K | ﹤0.01% |
45,336
+18,135
| +67% | +$294K |
|
|
IGAC
7872
CALL
DELISTED
IG Acquisition Corp. Class A Common Stock
IGAC
| $675K | ﹤0.01% |
68,200
-1,900
| -3% | -$18.8K |
|
7873
First Western Financial
MYFW
$311M
| $674K | ﹤0.01% |
24,780
+14,921
| +151% | +$465K |
|
7874
CALL
Invesco S&P 500 High Beta ETF
SPHB
$933M
| $674K | ﹤0.01% |
11,500
+3,500
| +44% | +$233K |
|
|
FREE
7875
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $674K | ﹤0.01% |
108,708
+9,865
| +10% | +$67.2K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.